EP2556088 - PLASMA-DERIVED IMMUNOGLOBULIN FOR USE IN THE TREATMENT AND PREVENTION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS) [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.10.2014 Database last updated on 22.08.2024 | Most recent event Tooltip | 24.10.2014 | Application deemed to be withdrawn | published on 26.11.2014 [2014/48] | Applicant(s) | For all designated states Universitätsspital Basel Hebelstrasse 32 4031 Basel / CH | [2013/07] | Inventor(s) | 01 /
KAPPOS, Ludwig Burgstrasse 57 CH-4125 Riehen / CH | 02 /
KUHLE, Jens Amselstrasse 29 CH-4104 Oberwil / CH | [2013/07] | Representative(s) | Peter, Beate, et al CSL Behring Patents & Licenses Emil-von-Behring-Strasse 76 35041 Marburg / DE | [2013/07] | Application number, filing date | 11714260.4 | 08.04.2011 | WO2011EP55480 | Priority number, date | EP20100003762 | 08.04.2010 Original published format: EP 10003762 | [2013/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011124668 | Date: | 13.10.2011 | Language: | EN | [2011/41] | Type: | A1 Application with search report | No.: | EP2556088 | Date: | 13.02.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.10.2011 takes the place of the publication of the European patent application. | [2013/07] | Search report(s) | International search report - published on: | EP | 13.10.2011 | Classification | IPC: | C07K16/00, A61P37/00 | [2013/07] | CPC: |
C07K16/00 (EP,US);
A61K39/39516 (US);
A61P37/00 (EP);
A61P37/02 (EP);
A61P39/00 (EP);
C07K16/2842 (EP,US);
A61K2039/505 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/07] | Title | German: | AUS PLASMA STAMMENDES IMMUNGLOBULIN ZUR VERWENDUNG BEI DER BEHANDLUNG UND PRÄVENTION VON INFLAMMATORISCHEN IMMUNREKONSTITUTIONSSYNDROM (IRIS) | [2013/07] | English: | PLASMA-DERIVED IMMUNOGLOBULIN FOR USE IN THE TREATMENT AND PREVENTION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME (IRIS) | [2013/07] | French: | IMMUNOGLOBULINE ISSUE DU PLASMA POUR L'UTILISATION DANS LE TRAITEMENT ET LA PRÉVENTION DU SYNDROME INFLAMMATOIRE DE RECONSTITUTION IMMUNE (IRIS) | [2013/07] | Entry into regional phase | 08.11.2012 | National basic fee paid | 08.11.2012 | Designation fee(s) paid | 08.11.2012 | Examination fee paid | Examination procedure | 02.11.2012 | Amendment by applicant (claims and/or description) | 08.11.2012 | Examination requested [2013/07] | 06.12.2013 | Despatch of a communication from the examining division (Time limit: M06) | 17.06.2014 | Application deemed to be withdrawn, date of legal effect [2014/48] | 11.07.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/48] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 06.12.2013 | Fees paid | Renewal fee | 02.05.2013 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.04.2014 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI] - CLIFFORD DAVID B ET AL, "Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.", LANCET NEUROLOGY APR 2010 LNKD- PUBMED:20298967, (20100316), vol. 9, no. 4, ISSN 1474-4465, pages 438 - 446, XP026969520 [X] 1-4,7-17 * abstract; table 2 * [I] 5,6 | [I] - MURDOCH DAVID M ET AL, "Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.", AIDS RESEARCH AND THERAPY 2007 LNKD- PUBMED:17488505, (2007), vol. 4, ISSN 1742-6405, page 9, XP021025355 [I] 5,6 * whole document, in particular abstract * DOI: http://dx.doi.org/10.1186/1742-6405-4-9 | [A] - BEISHUIZEN S J E ET AL, "Immune reconstitution inflammatory syndrome: immunopathogenesis, risk factors, diagnosis, treatment and prevention", NETHERLANDS JOURNAL OF MEDICINE, (200911), vol. 67, no. 10, ISSN 0300-2977, pages 327 - 331, XP009137248 [A] 1-17 * abstract * | [A] - TAN CHEN S ET AL, "Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.", LANCET NEUROLOGY APR 2010 LNKD- PUBMED:20298966, (20100316), vol. 9, no. 4, ISSN 1474-4465, pages 425 - 437, XP026969519 [A] 1-17 * the whole document * DOI: http://dx.doi.org/10.1016/S1474-4422(10)70040-5 | [A] - BRETON GUILLAUME, "[Immune reconstitution inflammatory syndrome or IRIS]", MÉDECINE SCIENCES : M/S MAR 2010 LNKD- PUBMED:20346278, (201003), vol. 26, no. 3, ISSN 0767-0974, pages 281 - 289, XP009137287 [A] 1-17 * the whole document * | [A] - ACHIRON ANAT ET AL, "Intravenous immunoglobulin and multiple sclerosis.", CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY DEC 2005 LNKD- PUBMED:16391400, (200512), vol. 29, no. 3, ISSN 1080-0549, pages 247 - 254, XP009137291 [A] 1-17 * the whole document * DOI: http://dx.doi.org/10.1385/CRIAI:29:3:247 | [A] - LANGER-GOULD ANNETTE ET AL, "Brief report - Progressive multifocal leukoencephalopathy in a patient treated with natalizumab", NEW ENGLAND JOURNAL OF MEDICINE, THE, MASSACHUSETTS MEDICAL SOCIETY, WALTHAM, MA, US, (20050728), vol. 353, no. 4, ISSN 0028-4793, pages 375 - 381, XP009123696 [A] 1-17 * the whole document * | [A] - LIPMAN MARC ET AL, "Immune reconstitution inflammatory syndrome in HIV.", CURRENT OPINION IN INFECTIOUS DISEASES FEB 2006 LNKD- PUBMED:16374213, (200602), vol. 19, no. 1, ISSN 0951-7375, pages 20 - 25, XP009137245 [A] 1-17 * abstract * DOI: http://dx.doi.org/10.1097/01.qco.0000200543.80712.01 | by applicant | WO2008083680 | - WAGNER, Z. RHEUMATOL., (2008), vol. 67, pages 284 - 289 | - BEIZHUISEN, GEERLINGS, THE NETHERLANDS JOURNAL OF MEDICINE, (2009), vol. 67, pages 327 - 332 | - HENDERSON ET AL., BR. J. OPHTALMOL, (1999), vol. 83, pages 540 - 545 | - SINGH ET AL., TRANSPLANTATION, (2005), vol. 80, pages 1131 - 1133 | - ALON R ET AL., J CELL BIOL, (1995), vol. 128, no. 6, pages 1243 - 1253 | - JOHNSTON B, KUBES P., IMMUNOL TODAY, (1999), vol. 20, no. 12, pages 545 - 550 | - ARROYO AG ET AL., CELL, (1996), vol. 85, no. 7, pages 997 - 1008 | - COISNE C ET AL., J IMMUNOL, (2009), vol. 182, no. 10, pages 5909 - 5913 | - POLMAN CH ET AL., N ENGL J MED, (2006), vol. 354, no. 9, pages 899 - 910 | - RUDICK RA, PANZARA MA., BIOLOGICS, (2008), vol. 2, no. 2, pages 189 - 199 | - KNOWLES WA ET AL., J MED VIROL, (2003), vol. 71, no. 1, pages 115 - 123 | - WENNING ET AL., N. ENGL. J. MED., (2009), vol. 361, pages 1075 - 1080 | - CARSON ET AL., LANCET ONCOLOGY, (2009), vol. 10, pages 816 - 823 | - ALLISON ET AL., NAT. BIOTECH., (2010), vol. 28, pages 105 - 106 | - LANGER-GOULD ET AL., N, ENGL. J. MED., (2005), vol. 353, pages 375 - 381 | - PADATE ET AL., CLIN. LAB. HAEM., (2006), vol. 28, pages 69 - 71 | - STROVE ET AL., ARCH. NEUROL., (2007), page 64 | - AHMED ET AL., N. ENGL. J. MED., (2006), vol. 355, pages 1772 - 1778 | - COOPER ET AL., BRITISH JOURNAL OF HEMATOLOGY, (2009), vol. 146, pages 120 - 122 | - HARTUNG ET AL., CLIN. EXP. IMMUNOL., (2009), vol. 158, no. 1, pages 23 - 33 | - SHARMA ET AL., BLOOD, (2000), vol. 96, pages 1184 - 1186 | - K6HLER, MILSTEIN, NATURE, (1975), vol. 256, pages 495 - 497 | - KOZBOR, IMMUNOLOGY TODAY, (1983), vol. 4, page 72 | - COLE ET AL., Monoclonal Antibodies and Cancer Therapy, ALAN R. LISS, INC., (1985), pages 77 - 96 | - CROWDER CD ET AL., AM J TRANSPLANT, (2005), vol. 5, no. 5, pages 1151 - 1158 | - SHITRIT D ET AL., TRANSPL INT, (2005), vol. 17, no. 11, pages 658 - 665 | - KAPPOS L ET AL., LANCET NEUROL, (2007), vol. 6, no. 5, pages 431 - 441 | - CRUM-CIANFLONE NF, AIDS READ, (2006), vol. 16, no. 4, pages 199 - 217 | - SHELBURNE SA ET AL., MEDICINE (BALTIMORE), (2002), vol. 81, no. 3, pages 213 - 227 | - KHATRI BO ET AL., NEUROLOGY, (2009), vol. 72, no. 5, pages 402 - 409 | - MILLER DH ET AL., N ENGL J MED, (2003), vol. 348, no. 1, pages 15 - 23 | - STUVE O ET AL., ARCH NEUROL, (2006), vol. 63, no. 10, pages 1383 - 1387 | - PROF. H.H. HIRSCH, Clinical and Transplantation Virology, INSTITUTE FOR MEDICAL MICROBIOLOGY | - SWITZERLAND, PROF. K. MUHIEMANN, Clinical Microbiology | - RYSCHKEWITSCH C ET AL., J VIROL METHODS, (2004), vol. 121, no. 2, pages 217 - 221 | - FELGENHAUER K ET AL., J NEUROL SCI, (1976), vol. 30, no. 1, pages 113 - 128 | - REIBER H, FELGENHAUER K, CLIN CHIM ACTA, (1987), vol. 163, no. 3, pages 319 - 328 |